Thomas Rohrer
Lonza Pharma & Biotech, USA
Biography
Thomas Rohrer is Associate Director of Bioconjugate Commercial Development at Lonza and has over 30 years of experience in biotherapeutic process development, scale-up and manufacturing. He holds a BS in Biochemistry and MS in Chemical Engineering. He established process development and clinical manufacturing of ADC(s) at Cambrex Biopharma in 2005. After Cambrex Biopharma was acquired by Lonza in 2007 he joined the Lonza Exclusive Synthesis ADC business team in Visp, Switzerland. Prior to joining Lonza he held senior positions in biotherapeutics process development and manufacturing at Human Genome Sciences, Otsuka Pharmaceutical and the National Cancer Institute (NCI) - Frederick Cancer Research Facility.
Abstract
Abstract : Developing and manufacturing the next generation of bioconjugates